Your Article Summary
Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features
Mylan, 10/27/09
Dey Pharma, L.P., a subsidiary of Mylan Inc., launched a newly designed, patient–friendly EpiPen Auto–Injector 0.3/0.15 mg. This next–generation EpiPen Auto–Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto–Injector with several new, user–friendly features, including being the only auto–injector with needle–protection before and after use.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor


See Latest Articles


